Cargando…
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
BACKGROUND AND AIMS: Anthracyclines are highly effective chemotherapeutic agents which may cause long-term cardiac damage (chronic anthracycline cardiotoxicity) and heart failure. The pathogenesis of anthracycline cardiotoxicity remains incompletely understood and individual susceptibility difficult...
Autores principales: | Kotwinski, Paul, Smith, Gillian, Cooper, Jackie, Sanders, Julie, Ma, Louise, Teis, Albert, Kotwinski, David, Mythen, Michael, Pennell, Dudley J., Jones, Alison, Montgomery, Hugh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135038/ https://www.ncbi.nlm.nih.gov/pubmed/27911951 http://dx.doi.org/10.1371/journal.pone.0165262 |
Ejemplares similares
-
CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging
por: Kotwinski, Paul, et al.
Publicado: (2013) -
Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
por: Smith, Gillian, et al.
Publicado: (2009) -
The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity
por: Kotwinski, Paul, et al.
Publicado: (2013) -
Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
por: Hu, Hui-Min, et al.
Publicado: (2018) -
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
por: Araujo-Gutierrez, Raquel, et al.
Publicado: (2021)